` Comparison: MD vs FRE - Alpha Spread

MD
vs
FRE

Over the past 12 months, MD has outperformed FRE, delivering a return of +37% compared to the FRE's +18% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MD
FRE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

MD Intrinsic Value
HIDDEN
Show
FRE Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
MEDNAX Inc
NYSE:MD
19.56 USD
Fresenius SE & Co KGaA
XETRA:FRE
46.92 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MD, FRE

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
MEDNAX Inc
Revenue
Fresenius SE & Co KGaA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
MD, FRE

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
MEDNAX Inc
NYSE:MD
Fresenius SE & Co KGaA
XETRA:FRE
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

MD
0%
FRE
24.9%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

Operating Margin

MD
12.1%
FRE
10.1%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

Net Margin

MD
8.6%
FRE
5.5%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

FCF Margin

MD
13.2%
FRE
5.2%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

ROE

MD
20.3%
FRE
6.6%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

ROA

MD
7.5%
FRE
2.9%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

ROIC

MD
10.3%
FRE
4.5%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

ROCE

MD
13.2%
FRE
6.9%
LTM 3Y Avg 5Y Avg 10Y Avg
MEDNAX Inc
Fresenius SE & Co KGaA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
MD, FRE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MD, FRE

Performance Gap Between MD and FRE
HIDDEN
Show

Performance By Year
MD, FRE

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MD to other stocks
CVS
CVS Health Corp
Cheaper
vs MD
CGN
Cigna Group
C
Cheaper
vs MD
CI
Cigna Corp
Cheaper
vs MD
FME
Fresenius Medical Care AG
More expensive
vs MD
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett